Suchergebnisse - "BNT162 Vaccine"

PubPharm (3.927)

91

The humoral response to COVID-19 vaccinations can predict the booster effect on health care workers-toward personalized vaccinations?

enthalten in: Journal of public health (Oxford, England) | 2024

von Freund, O. | Harish, A. | Breslavsky, A. | +4

92

Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in Germany

enthalten in: The Lancet. Infectious diseases | 2024

von Cossmann, A. | Hoffmann, M. | Stankov, M. | +7

93

Comparative efficacy and safety of COVID-19 vaccines in phase III trials : a network meta-analysis

enthalten in: BMC infectious diseases | 2024

von Wu, X. | Xu, K. | Zhan, P. | +4

94

Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults : the C4R Study

enthalten in: Nature communications | 2024

von Kim, J. | Sun, Y. | Balte, P. | +30

95

Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From COVID-19 in Adults Aged ≥70 Years

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Lopez Bernal, J. | Andrews, N. | Gower, C. | +4

96

The importance of falsification endpoints in observational studies of vaccination to prevent severe disease : A critique of a harm-benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds

enthalten in: Epidemiology and infection | 2024

von Høeg, T. | Haslam, A. | Prasad, V.

97

Risk of Herpes Zoster Ophthalmicus After COVID-19 Vaccination in a Large US Health Care Claims Database

enthalten in: American journal of ophthalmology | 2024

von Akpandak, I. | Sechrist, S. | Claire Miller, D. | +4

98

Real-World Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents

enthalten in: Annals of internal medicine | 2024

von Wu, Q. | Tong, J. | Zhang, B. | +25

UpdateOf: medRxiv. 2023 Nov 13;:. - PMID 38014095

99

A 12-month follow-up study of patients with systemic lupus erythematosus after immunization against SARS-CoV-2

enthalten in: Lupus | 2024

von Zavala-Flores, E. | Salcedo-Matienzo, J. | Huamanchumo-Guzman, R. | +2

100

Short term safety of BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine among children aged 5-11 years, a nationwide parental survey

enthalten in: Vaccine | 2024

von Shapiro Ben David, S. | Baruch Gez, S. | Adler, L. | +5